【2024 ASH】TransThera Announces the Phase I Study Results of TT-01488, a Novel Non-Covalent BTK Inhibitor, in Patients with Relapsed or Refractory B-cell Malignancies

NANJING, China and GAITHERSBURG, Md., Dec. 10, 2024 /PRNewswire/ — TransThera Sciences (Nanjing),…

Live from ASH 2024 | Oral Report Features Encouraging Data of Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax in R/R MM, Including a Median PFS Over 9 Months

ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2024 /PRNewswire/ — Ascentage Pharma…

Bruce ATS™ Set to Launch: A New Era of Overnight Trading

Leverages Nasdaq’s advanced and trusted platform to offer market participants an industry-leading…

Bybit Expands On-Chain Earn Offering with SUI Staking

DUBAI, UAE, Dec. 10, 2024 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange…

Live from ASH 2024 | Ascentage Pharma Releases Updated Data of Bcl-2 Inhibitor Lisaftoclax in MDS that Demonstrates Potential Clinical Benefits and Favorable Safety

ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2024 /PRNewswire/ — Ascentage Pharma…

Bybit Launches On-Chain Earn: Up to 3% APR with $cmETH and Guaranteed ETH Rewards

DUBAI, UAE, Dec. 10, 2024 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange…

Young visitors savor Jiangsu's floral beauty mingled with economic prowess

BEIJING, Dec. 10, 2024 /PRNewswire/ — A news report from China Daily:…

Capture, Celebrate, and Save Big: Reolink's Holiday Deals and #reocap Fun!

LOS ANGELES, Dec. 10, 2024 /PRNewswire/ — This holiday season, Reolink, an…